Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Tata Stl 426.60 1.32
Hindalco 144.70 0.00
Bhel 189.30 1.42
Larsen & 1377.30 2.48
Wipro Lt 525.00 1.19
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Themis Medicare Limited
Themis Medicare Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:530199NSE:THEMISMEDBloomberg:TMCH@INReuters:THEM.BO
Market Lot: 1Face Value: 10ISIN Demat: INE083B01016
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
17-SEP-13 Themis Medicare announced that the company is agreed to manufacture and supply and Novartis has agreed long-term exclusive purchase from Themis Diclofenac Sodium 75 mg per ml Injection as finished dosage pharmaceutical form on certain commercial terms and conditions for Indian market. 12-APR-13 Themis Medicare, the company pioneer in Indian Pharmaceuticals Business, has announced it has agreed to manufacture and supply and Novartis h...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Themis Medicare inks long term supply pact with Novartis  -IRIS 17-Sep-13
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Dec-2013(9)31-Mar-2013 (12)31-Mar-2012 (12)
Net sales 1361.501439.331348.57
Other Income16.6332.3921.78
Total Income1378.131471.721370.35
Cost of goods sold1244.421390.591564.75
OPBDIT133.7181.13-194.40
PAT14.70-81.26-346.74
Gross Block---
Equity capital80.5180.5180.51
EPS (Rs.)--10.09-43.07
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-NANA
Debt / Equity (x)---
Operating margin (% of OI) 9.7 5.5-14.2
Net margin (% of OI) 1.1-5.5-25.3
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Plot No 69/ A
GIDC Industrial Estate
District Valsad
Vapi
Gujarat-396 195
PHONE
- - -
FAX
- - -
 
Board of Directors
Board Meetings
Date Purpose
14-MAY-14 Audited Results
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer